Personal care product and human health /

Personal Care Products and Human Health provides background, historical context and the latest research results on personal care products (PCPs) and their impact on human health and the environment. Sections provide an overview of the functions and mechanisms of action of components of personal care...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Carbre, Philippa D.
Format: eBook
Language:English
Published: London ; San Diego, CA : Academic Press, an imprint of Elsevier, [2023]
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Front Cover
  • PERSONAL CARE PRODUCTS AND HUMAN HEALTH
  • PERSONAL CARE PRODUCTS AND HUMAN HEALTH
  • Copyright
  • Contents
  • Contributors
  • Preface
  • 1
  • Introduction to the constituents of PCPs and their functions
  • 1
  • Introduction to personal care products
  • 1.1 Introduction
  • 1.2 Historical background
  • 1.3 Sites of exposure of the human body to personal care products
  • 1.3.1 Human skin
  • 1.3.2 Human hair
  • 1.3.3 Human respiratory system
  • 1.3.4 Human oral cavity
  • 1.3.5 Human female genitalia
  • 1.4 Functional components of personal care products
  • 1.4.1 Cleansers, surfactants, and abrasives
  • 1.4.2 Conditioning and moisturizing agents
  • 1.4.3 Solvents, emulsifiers, spreading agents, penetration enhancers, and plasticizers
  • 1.4.4 Thickening and stiffening agents
  • 1.4.5 Preservatives
  • 1.4.6 Deodorants
  • 1.4.7 Antiperspirant
  • 1.4.8 Dehydrators
  • 1.4.9 UV filters
  • 1.4.10 Fragrance and fragrance fixers
  • 1.4.11 Coloring agents
  • 1.4.12 Biocides
  • 1.5 Cosmeceuticals
  • 1.6 Age- and gender-targeted products
  • 1.7 Product format and packaging
  • 1.8 Benefits, adverse effects, and arising concerns
  • 1.9 Concluding comments
  • References
  • 2
  • Overview of constituent compounds with concerns for adverse effects on human health
  • 2.1 Introduction
  • 2.2 Widely used constituent chemicals with arising human health concerns
  • 2.2.1 Formaldehyde
  • 2.2.2 Parabens
  • 2.2.3 Triclosan
  • 2.2.4 Phthalates
  • 2.2.5 Bisphenols
  • 2.2.6 UV filters
  • 2.2.7 Fragrance and fragrance fixers
  • 2.2.8 Aluminum salts
  • 2.2.9 Cyclic volatile methylsiloxanes
  • 2.2.10 Coal tar
  • 2.2.11 Talcum powder
  • 2.2.12 Dyes and coloring agents
  • 2.2.13 Acrylates
  • 2.2.14 Heavy metals
  • 2.3 Nanomaterials
  • 2.4 Natural versus synthetic compounds
  • 2.5 Long-term low-dose mixtures
  • 2.6 Early life exposures
  • 2.7 Concluding comments.
  • 7.8 Cyclic volatile methylsiloxanes
  • 7.9 Concluding comments
  • References
  • 3
  • Human health concerns
  • 8
  • Contact dermatitis
  • 8.1 Introduction
  • 8.2 Global burden and increasing prevalence of PCP-related contact dermatitis
  • 8.3 Anatomical sites of PCP-related contact dermatitis
  • 8.4 Causative PCP components
  • 8.4.1 Fragrance
  • 8.4.2 Preservatives
  • 8.4.3 p-substances
  • 8.4.4 Polypropylene glycol and lanolin
  • 8.4.5 Sunscreens and photocontact allergens
  • 8.5 Concluding comments
  • References
  • 9
  • Respiratory irritation and sensitization
  • 9.1 Introduction
  • 9.2 The respiratory tract as a target for inhaled ingredients of personal care products
  • 9.3 Components of personal care products as pollutants of indoor air
  • 9.4 Occupational asthma in beauty salon workers
  • 9.5 Fragrance and asthma
  • 9.6 Talcum powder
  • 9.7 Nanoparticles
  • 9.8 Early life exposures and adult lung function
  • 9.9 Concluding comments
  • References
  • 10
  • Endocrine disruption
  • 10.1 Introduction: What are endocrine-disrupting chemicals and where are they found in personal care products?
  • 10.2 Evidence that endocrine-disrupting chemicals are absorbed from dermal application of personal care products
  • 10.3 Evidence that chemical constituents of personal care products possess endocrine-disrupting properties
  • 10.3.1 Disruption of estrogen receptor-mediated mechanisms
  • 10.3.2 Disruption of other steroid receptors
  • 10.3.3 Disruption of thyroid hormone receptor-mediated mechanisms
  • 10.3.4 Disruption of peroxisome proliferator-activated receptor mechanisms
  • 10.3.5 Endocrine disruption through the aryl hydrocarbon receptor
  • 10.3.6 Endocrine disruption through mixtures of chemicals
  • 10.3.7 Endocrine disruption from long-term exposures
  • 10.3.8 Nonmonotonic dose responses of endocrine disruptors.
  • 10.3.9 Tissue-specific effects of endocrine disruption
  • 10.4 Evidence that endocrine-disrupting chemicals contained in personal care products can affect human health
  • 10.4.1 Direct evidence for human endocrine disruption following topical exposure to hormonally active compounds
  • 10.4.2 Evidence that increased tissue levels of endocrine-disrupting chemicals originating from personal care products correlate w ...
  • 10.4.2.1 Male reproductive health
  • 10.4.2.2 Female reproductive health
  • 10.5 Concluding comments
  • References
  • 11
  • Early life exposure and developmental consequences
  • 11.1 Introduction
  • 11.2 Evidence for placental transfer of chemicals in personal care products
  • 11.3 Evidence for transfer of chemicals in personal care products during breast feeding
  • 11.4 Early life exposures and disruption of endocrine-regulated developmental pathways
  • 11.4.1 Male reproductive health
  • 11.4.2 Female reproductive health
  • 11.4.3 Neurodevelopment disorders
  • 11.4.4 Obesity
  • 11.4.5 Epigenetic alterations in utero and transgenerational transmission
  • 11.5 Early life exposures and susceptibility to dermatitis
  • 11.6 Early life exposures and susceptibility to respiratory disease
  • 11.7 Early life exposures and susceptibility to cancer development
  • 11.8 Concluding comments
  • References
  • 12
  • Development of cancer
  • 12.1 Introduction
  • 12.2 Chemical ingredients in personal care products and the hallmarks of cancer
  • 12.3 Individual susceptibility and lifestyle choices
  • 12.4 Lifestyle choices and the tumor microenvironment
  • 12.5 Personal care products and breast cancer
  • 12.5.1 Endocrine-disrupting chemicals and breast cancer
  • 12.5.2 The case for a link between underarm cosmetics and breast cancer
  • 12.5.3 Chemical ingredients and the hallmarks of breast cancer
  • 12.5.3.1 Sustained proliferation.
  • 12.5.3.2 Resistance to cell death
  • 12.5.3.3 Evasion of growth suppressors
  • 12.5.3.4 Replicative immortality
  • 12.5.3.5 Invasion and metastasis
  • 12.5.3.6 Induction of angiogenesis
  • 12.5.3.7 Avoidance of immune destruction
  • 12.5.3.8 Deregulation of cell metabolism
  • 12.5.3.9 Genome instability and mutation
  • 12.5.3.10 Tumor-promoting inflammation
  • 12.5.4 Antiperspirants and breast cysts
  • 12.6 Personal care products and cancers in other endocrine-sensitive tissues
  • 12.7 Personal care products and endocrine therapy of cancer
  • 12.8 Talcum powder and ovarian cancer
  • 12.9 Sun care products and skin cancer
  • 12.10 Concluding comments
  • References
  • 13
  • Aluminum and its carcinogenic traits
  • 13.1 Introduction
  • 13.2 Carcinogens and carcinogenic metals
  • 13.3 Aluminum
  • 13.3.1 Generalities
  • 13.3.2 Aluminum toxicity
  • 13.3.3 Aluminum as a putative carcinogen
  • 13.3.3.1 Epidemiological studies in breast cancer
  • 13.3.3.2 Experimental data
  • 13.3.3.2.1 Aluminum transforms mammary epithelial cells in vitro
  • 13.3.3.2.2 Mammary epithelial cells transformed by aluminum in vitro form tumors and metastasis in vivo
  • 13.3.3.2.3 Mechanisms of aluminum-induced cellular transformation
  • 13.4 Conclusions
  • References
  • 4
  • Regulatory considerations
  • 14
  • Regulatory considerations and public education
  • 14.1 Introduction
  • 14.2 How is regulation brought about in different countries?
  • 14.3 Challenges for risk assessment of personal care products
  • 14.3.1 Advantages and disadvantages of different types of evidence
  • 14.3.2 Importance of tissue-specific risk assessment
  • 14.3.3 Special considerations for endocrine-disrupting chemicals
  • 14.3.4 Genotoxicity
  • 14.3.5 Nanomaterials
  • 14.3.6 Cosmeceuticals
  • 14.3.7 Long-term low-dose mixtures
  • 14.4 Role of nongovernmental organizations and the mass media.